acamprosate calcium (Zydus Pharmaceuticals (USA) Inc.)
Welcome to the PulseAid listing for the acamprosate calcium drug offered from Zydus Pharmaceuticals (USA) Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Zydus Pharmaceuticals (USA) Inc. |
NON-PROPRIETARY NAME: | acamprosate calcium |
SUBSTANCE NAME: | ACAMPROSATE CALCIUM |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, DELAYED RELEASE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-06-01 |
END MARKETING DATE: | 0000-00-00 |
acamprosate calcium HUMAN PRESCRIPTION DRUG Details:
Item Description | acamprosate calcium from Zydus Pharmaceuticals (USA) Inc. |
LABELER NAME: | Zydus Pharmaceuticals (USA) Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 333(mg/1) |
START MARKETING DATE: | 2017-06-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68382-569_fd2af2f5-8924-4fbb-bb50-c233640c33fa |
PRODUCT NDC: | 68382-569 |
APPLICATION NUMBER: | ANDA205995 |
Other ACAMPROSATE CALCIUM Pharmaceutical Manufacturers / Labelers: